These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.
    Author: Ono M, Tsuda H, Yoshida M, Shimizu C, Kinoshita T, Tamura K.
    Journal: Clin Breast Cancer; 2017 Feb; 17(1):41-47. PubMed ID: 27477822.
    Abstract:
    INTRODUCTION: We showed the clinical implications of the Ki-67 labeling index (LI) in hormone receptor (HR)-positive, HER2-negative (HER2-) breast cancer patients with lower risk (luminal A [LA]-like) and higher risk (luminal B [LB]-like) subtypes. PATIENTS AND METHODS: Three hundred sixty-nine patients with HR+, HER2- cancers were eligible and we dichotomized these patients into LA-like and LB-like according to Ki-67 LI (14% cutoff) and analyzed prognostic significance of progesterone receptor (PR) expression. RESULTS: Of 205 LA-like and 163 LB-like subtypes, PR was positive in 149 (73%) and 103 (63%). PR expression was a prognostic factor in the LA-like subtype but not in the LB-like subtype. In LA/PR+, LA/PR-, and LB-like subtypes, the 12-year disease-free survival (DFS) rates were 94.8%, 81.6%, and 79.7% (P = .03), and breast cancer-specific survival (BCSS) rates were 98.4%, 97.4%, and 92.0%, respectively (P = .05). Late recurrence occurred in LA/PR- subtype, and differences in prognosis between LA/PR+ and LA/PR- subtypes emerged >5 years after surgery. Twelve-year DFS rates of the LA/PR- subtype were almost equal to those of the LB-like subtype, whereas 12-year BCSS of the LA/PR- subtype was superior to that of the LB-like subtype. In multivariate analysis, PR expression and tumor size were significant or nearly significant prognostic factors. CONCLUSION: PR expression and tumor size were independent prognostic factors in the LA-like subtype, and the LA/PR- subtype had the higher risk of recurrence, especially late recurrence, than the LA/PR+ subtype. In LA-like breast cancers, stratification of prognosis according to PR expression and tumor size is important.
    [Abstract] [Full Text] [Related] [New Search]